BioCryst Pharmaceuticals BCRX Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's gain loss on foreign currency derivative instruments not designated as hedging instruments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's gain loss on foreign currency derivative instruments not designated as hedging instruments?
- BioCryst Pharmaceuticals (BCRX) reported gain loss on foreign currency derivative instruments not designated as hedging instruments of -$225K in Q1 2026.
- How has BioCryst Pharmaceuticals's gain loss on foreign currency derivative instruments not designated as hedging instruments changed year-over-year?
- BioCryst Pharmaceuticals's gain loss on foreign currency derivative instruments not designated as hedging instruments decreased by 22600.0% year-over-year, from $1K to -$225K.
- What is the long-term trend for BioCryst Pharmaceuticals's gain loss on foreign currency derivative instruments not designated as hedging instruments?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's gain loss on foreign currency derivative instruments not designated as hedging instruments has grown at a -31.6% compound annual growth rate (CAGR), from -$695K to -$152K.
- What does gain loss on foreign currency derivative instruments not designated as hedging instruments mean?
- The net gain or loss recognized from financial instruments used to hedge or manage exposure to foreign currency exchange rate fluctuations. This reflects the impact of currency volatility on the company's international financial positions and the effectiveness of its hedging strategies.